The ADXS chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ADXS chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The ADXS stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View ADXS Detailed Price Forecast - CNN Money||View ADXS Detailed Summary - Google Finance|
|View ADXS Detailed Summary - Yahoo! Finance||View ADXS Stock Research & Analysis - Zacks.com|
|View ADXS Trends & Analysis - Trade-Ideas||View ADXS Major Holders - Barrons|
|View ADXS Call Transcripts - NASDAQ||View ADXS Breaking News & Analysis - Seeking Alpha|
|View ADXS Annual Report - CompanySpotlight.com||View ADXS OTC Short Report - OTCShortReport.com|
|View ADXS Fundamentals - TradeKing||View ADXS SEC Filings - Bar Chart|
|View Historical Prices for ADXS - The WSJ||View Performance/Total Return for ADXS - Morningstar|
|View the Analyst Estimates for ADXS - MarketWatch||View the Earnings History for ADXS - CNBC|
|View the ADXS Earnings - StockMarketWatch||View ADXS Buy or Sell Recommendations - MacroAxis|
|View the ADXS Bullish Patterns - American Bulls||View ADXS Short Pain Metrics - ShortPainBot.com|
|View ADXS Stock Mentions - StockTwits||View ADXS Stock Mentions - PennyStockTweets|
|View ADXS Stock Mentions - Twitter||View ADXS Investment Forum News - Investor Hub|
|View ADXS Stock Mentions - Yahoo! Message Board||View ADXS Stock Mentions - Seeking Alpha|
|View Insider Transactions for ADXS - SECform4.com||View Insider Transactions for ADXS - Insider Cow|
|View ADXS Major Holdings Summary - CNBC||View Insider Disclosure for ADXS - OTC Markets|
|View Insider Transactions for ADXS - Yahoo! Finance||View Institutional Holdings for ADXS - NASDAQ|
|View ADXS Stock Insight & Charts - FinViz.com||View ADXS Investment Charts - StockCharts.com|
|View ADXS Stock Overview & Charts - BarChart||View ADXS User Generated Charts - Trading View|
BriaCell Appoints Richard J. Berman to Board of Directors
Posted on Monday August 12, 2019
BERKELEY, Calif., and VANCOUVER, British Columbia, Aug. 12, 2019 -- BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF), a clinical-stage.
Advaxis, Inc. Announces Closing of $17 Million Public Offering and Exercise in Full of the Underwriters' Over-Allotment Option
Posted on Thursday July 25, 2019
Advaxis, Inc. (ADXS) (the “Company”), a clinical-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, today announced the closing of its previously announced underwritten public offering of (i) 10,650,000 shares of common stock together with common stock warrants (the “common warrants”) to purchase 7,987,500 shares of common stock and (ii) 13,656,000 pre-funded warrants, with each pre-funded warrant exercisable for one share of common stock, together with common warrants to purchase 10,242,000 shares of common stock, which included the exercise in full of the over-allotment option to purchase additional shares of common stock and warrants.
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 23) Akero Therapeutics Inc (NASDAQ: AKRO ) Mirum Pharmaceuticals ...
Advaxis, Inc. Announces Pricing of $16 Million Public Offering
Posted on Tuesday July 23, 2019
Advaxis, Inc. (ADXS) (the “Company”), a clinical-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, today announced the pricing of an underwritten public offering of (i) 9,200,000 shares of common stock together with common stock warrants (the “common warrants”) to purchase 6,900,000 shares of common stock and (ii) 13,656,000 pre-funded warrants, with each pre-funded warrant exercisable for one share of common stock, together with common warrants to purchase 10,242,000 shares of common stock. The shares of common stock (or pre-funded warrants, as applicable) and accompanying common warrants are being sold together at a combined public offering price of $0.70 per share.